NCT01560364

Brief Summary

This is a prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2011

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 22, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
Last Updated

December 2, 2014

Status Verified

November 1, 2014

Enrollment Period

1.3 years

First QC Date

October 17, 2011

Last Update Submit

November 28, 2014

Conditions

Adults Receiving Renal Replacement Therapy

Keywords

Renal replacement therapyHemofilter clottingClotting risk factorHemofilter clotting prevention

Outcome Measures

Primary Outcomes (1)

  • Hemofilter lifetime

    at day 1

Secondary Outcomes (3)

  • Hemofilter clotting risk factors

    at day 1

  • hemofiltration duration

    at day 1

  • down time value

    at day 1

Study Arms (1)

Hemofilter

Other: renal replacement therapy

Interventions

renal replacement therapyOTHER

Prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Hemofilter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults receiving renal replacement therapy

You may qualify if:

  • Adult (age \> 18 years)
  • Renal replacement therapy (continuous veino-veinous hemofiltration or continuous veino-veinous hemodiafiltration)
  • Consent of patients

You may not qualify if:

  • Use citrate anticoagulation
  • Age below 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

Location

MeSH Terms

Interventions

Renal Replacement Therapy

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Sébastien PERBET

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2011

First Posted

March 22, 2012

Study Start

May 1, 2011

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

December 2, 2014

Record last verified: 2014-11

Locations

FR(1)